Market Overview:
The global sugar coated tablets market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for over-the-counter drugs, and technological advancements in the pharmaceutical industry. Based on type, the global sugar coated tablets market is segmented into colored sugar coated tablets and colorless sugar coated tablets. Colored sugar coated tablets are expected to account for a larger share of the market than colorless sugar coated tablets during the forecast period. This can be attributed to their higher demand from applications such as cardiovascular diseases, gastrointestinal disease, neurological diseases, and immune disease. Based on application, the global sugar coated tablet market is segmented into cardiovascular diseases, gastrointestinal disease Neurological Diseases Immune Disease Others .
Product Definition:
A sugar-coated tablet is a pharmaceutical dosage form in which the drug is coated with a layer of sugar. The purpose of this coating is to protect the drug from stomach acids, and to improve its palatability.
Colored Sugar Coated Tablets:
Colored sugar coated tablets are used as a coating in medicines and other nutritional supplements. The coating is applied to the tablet so that it can be identified by the patient and also because different colors indicate different drugs or supplements. Colored sugar coated tablets are available in both immediate release and extended release forms, which have slightly different drug mixtures depending on their usage.
Colorless Sugar Coated Tablets:
The colorless sugar coated tablets are used in the treatment of diabetes. The active ingredient in these tablets is called “N-Acetyl-cocamine” or simply NAC for short. It is a naturally occurring compound found in the skin of grapes as well as other fruits such as plums, apples, pears and berries among others.
Application Insights:
Cardiovascular diseases segment held the largest market share in 2017. Sugar coated tablets are used for the treatment of cardiovascular diseases due to their positive impact on cholesterol levels. These factors along with growing awareness regarding risk factors associated with Cardiovascular Diseases (CVDs) is expected to drive product demand over the forecast period.
Asia Pacific is projected to witness significant growth in neurological disease treatment owing to increasing prevalence and aging population, especially in China and India. Furthermore, expansion of healthcare facilities coupled with rising spending capacity in countries like Australia will further boost industry size by 2030.
The gastrointestinal disease segment held a substantial market share and is expected to grow at a lucrative rate during the forecast period owingto high product usage for treating diarrhea & nausea caused by various causes such as food poisoning, infections etcetera throughout Asia Pacific region which includes China, Japan, Singapore Indonesia among others countries/regions within Asia Pacific region that suffer from frequent cases of Gastrointestinal Disease (GIT).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period, owing to high consumption of sugar coated tablets in daily dosage forms such as chewable/lozenges and capsules/pills. In addition, increasing R&D activities for new product development and technological innovations are projected to fuel growth over the coming years.
Asia Pacific is anticipated to be one of the fastest growing regions during the forecast period owing to rising geriatric population base that requires long-term treatment with medication, coupled with an increase in chronic diseases leading towards higher healthcare expenditure levels within countries such as China and India.
Growth Factors:
- Rising demand for sugar-free food products: The global market for sugar-free food products is projected to grow at a CAGR of 6.5% from 2016 to 2021. This growth can be attributed to the increasing awareness about the health benefits of sugar-free foods among consumers, especially in developed countries. Sugar Coated Tablets are witnessing increasing demand as a key ingredient in sugar-free food products, due to their ability to provide sweetness and flavor without adding any calories or carbohydrates.
- Growing popularity of functional foods: Functional foods are those that offer additional health benefits beyond basic nutrition. They are becoming increasingly popular among consumers due to the rising awareness about the importance of healthy eating habits. Sugar Coated Tablets are being used as key ingredients in many functional food formulations, owing to their ability to improve taste and texture while providing added health benefits such as weight management and diabetes control/prevention.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sugar Coated Tablets Market Research Report
By Type
Colored Sugar Coated Tablets, Colorless Sugar Coated Tablets
By Application
Cardiovascular Diseases, Gastrointestinal Disease, Neurological Diseases, Immune Disease, Others
By Companies
Pfizer, Novartis, Yangze River Pharmacelltcal, Bayer, XINHUA PHARMACEUTICAL, Harbin Pharmaceutical, Eisai, NCPC, GSK, Gebro
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Sugar Coated Tablets Market Report Segments:
The global Sugar Coated Tablets market is segmented on the basis of:
Types
Colored Sugar Coated Tablets, Colorless Sugar Coated Tablets
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular Diseases, Gastrointestinal Disease, Neurological Diseases, Immune Disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Novartis
- Yangze River Pharmacelltcal
- Bayer
- XINHUA PHARMACEUTICAL
- Harbin Pharmaceutical
- Eisai
- NCPC
- GSK
- Gebro
Highlights of The Sugar Coated Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Colored Sugar Coated Tablets
- Colorless Sugar Coated Tablets
- By Application:
- Cardiovascular Diseases
- Gastrointestinal Disease
- Neurological Diseases
- Immune Disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sugar Coated Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sugar coated tablets are a type of medication that come in the form of small, round pills. They are designed to be easy to swallow and provide quick relief from symptoms such as pain, fever, and inflammation.
Some of the key players operating in the sugar coated tablets market are Pfizer, Novartis, Yangze River Pharmacelltcal, Bayer, XINHUA PHARMACEUTICAL, Harbin Pharmaceutical, Eisai, NCPC, GSK, Gebro.
The sugar coated tablets market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sugar Coated Tablets Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sugar Coated Tablets Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sugar Coated Tablets Market - Supply Chain
4.5. Global Sugar Coated Tablets Market Forecast
4.5.1. Sugar Coated Tablets Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sugar Coated Tablets Market Size (000 Units) and Y-o-Y Growth
4.5.3. Sugar Coated Tablets Market Absolute $ Opportunity
5. Global Sugar Coated Tablets Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Sugar Coated Tablets Market Size and Volume Forecast by Type
5.3.1. Colored Sugar Coated Tablets
5.3.2. Colorless Sugar Coated Tablets
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Sugar Coated Tablets Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Sugar Coated Tablets Market Size and Volume Forecast by Application
6.3.1. Cardiovascular Diseases
6.3.2. Gastrointestinal Disease
6.3.3. Neurological Diseases
6.3.4. Immune Disease
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Sugar Coated Tablets Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Sugar Coated Tablets Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Sugar Coated Tablets Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sugar Coated Tablets Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sugar Coated Tablets Demand Share Forecast, 2019-2029
9. North America Sugar Coated Tablets Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sugar Coated Tablets Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sugar Coated Tablets Market Size and Volume Forecast by Application
9.4.1. Cardiovascular Diseases
9.4.2. Gastrointestinal Disease
9.4.3. Neurological Diseases
9.4.4. Immune Disease
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Sugar Coated Tablets Market Size and Volume Forecast by Type
9.7.1. Colored Sugar Coated Tablets
9.7.2. Colorless Sugar Coated Tablets
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Sugar Coated Tablets Demand Share Forecast, 2019-2029
10. Latin America Sugar Coated Tablets Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sugar Coated Tablets Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sugar Coated Tablets Market Size and Volume Forecast by Application
10.4.1. Cardiovascular Diseases
10.4.2. Gastrointestinal Disease
10.4.3. Neurological Diseases
10.4.4. Immune Disease
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Sugar Coated Tablets Market Size and Volume Forecast by Type
10.7.1. Colored Sugar Coated Tablets
10.7.2. Colorless Sugar Coated Tablets
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Sugar Coated Tablets Demand Share Forecast, 2019-2029
11. Europe Sugar Coated Tablets Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sugar Coated Tablets Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sugar Coated Tablets Market Size and Volume Forecast by Application
11.4.1. Cardiovascular Diseases
11.4.2. Gastrointestinal Disease
11.4.3. Neurological Diseases
11.4.4. Immune Disease
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Sugar Coated Tablets Market Size and Volume Forecast by Type
11.7.1. Colored Sugar Coated Tablets
11.7.2. Colorless SugarCoated Tablets
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Sugar Coated Tablets Demand Share, 2019-2029
12. Asia Pacific Sugar Coated Tablets Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sugar Coated Tablets Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sugar Coated Tablets Market Size and Volume Forecast by Application
12.4.1. Cardiovascular Diseases
12.4.2. Gastrointestinal Disease
12.4.3. Neurological Diseases
12.4.4. Immune Disease
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Sugar Coated Tablets Market Size and Volume Forecast by Type
12.7.1. Colored Sugar Coated Tablets
12.7.2. Colorless Sugar Coated Tablets
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Sugar Coated Tablets Demand Share, 2019-2029
13. Middle East & Africa Sugar Coated Tablets Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Sugar Coated Tablets Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sugar Coated Tablets Market Size and Volume Forecast by Application
13.4.1. Cardiovascular Diseases
13.4.2. Gastrointestinal Disease
13.4.3. Neurological Diseases
13.4.4. Immune Disease
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Sugar Coated Tablets Market Size and Volume Forecast by Type
13.7.1. Colored Sugar Coated Tablets
13.7.2. Colorless Sugar Coated Tablets
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Sugar Coated Tablets Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Sugar Coated Tablets Market: Market Share Analysis
14.2. Sugar Coated Tablets Distributors and Customers
14.3. Sugar Coated Tablets Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Novartis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Yangze River Pharmacelltcal
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bayer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. XINHUA PHARMACEUTICAL
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Harbin Pharmaceutical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Eisai
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. NCPC
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. GSK
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Gebro
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
